Methods for amyloid removal using anti-amyloid antibodies
View Patent ↗Methods and related immunoglobulin peptides and fragments thereof are disclosed that enhance the cell-mediated immune response of a patient to deposits of amyloid fibrils. These methods exploit the opsonizing effect of antibodies directed toward amyloid material or its component parts.
1. A method of treating an amyloid deposition disease in a patient comprising administering to the patient at least one antibody or immunoglobulin polypeptide or fragment thereof which binds to human IgLC amyloid fibrils in an amount effective to enhance the cellular immune response of said patient to remove disease associated amyloid fibril deposits from said patient.
2. The method of claim 1 , wherein the antibody or immunoglobulin polypeptide or fragment thereof opsonizes said amyloid fibrils and induces removal of amyloid fibril deposits.
3. The method of claim 1 , wherein the antibody or immunoglobulin polypeptide or fragment thereof is a monoclonal antibody or fragment thereof.
4. The method of claim 3 , wherein the monoclonal antibody is selected from the group consisting of a humanized antibody, a chimeric antibody and a completely human antibody.
5. The method of claim 3 , wherein the monoclonal antibody is selected from the group consisting of κ1 (57-8H12), κ4 (11-1F4), λ8 (31-8C7) and combinations thereof.
6. The method of claim 3 , wherein the monoclonal antibody is selected from the group consisting of κ1 (57-8H12), κ4 (11-1F4), λ8 (31-8C7) and combinations thereof or a humanized or chimeric version of said monoclonal antibodies.
7. The method of claim 6 , wherein the monoclonal antibody is selected from the group consisting of a humanized antibody or a chimeric antibody.
8. The method of claim 1 , wherein the antibody is a labeled antibody.
9. The method of claim 1 , wherein the antibody or the immunoglobulin polypeptide or fragment thereof has been raised against an immunoglobulin light-chain.
10. The method of claim 1 , wherein the antibody or the immunoglobulin polypeptide or fragment thereof has been raised against synthetic amyloid fibrils.
11. The method of claim 1 , wherein the antibody or immunoglobulin polypeptide fragment is selected from the group consisting of a Fv fragment, Fab fragment, F(ab') fragment, F(ab') 2 fragment and ScFv fragment.
12. The method of claim 1 , wherein the antibody or the immunoglobulin polypeptide or fragment is a single chain antibody.
13. The method of claim 1 , wherein the antibody or the immunoglobulin polypeptide or fragment has cross-isotype reactivity.
14. The method of claim 1 , wherein the antibody or the immunoglobulin polypeptide or fragment is contained in a pharmaceutical composition further comprising a carrier.